China FDA clears Ra Medical Systems' dermatology laser

April 10, 2017

Ra Medical Systems has received China Food and Drug Administration approval for its Pharos excimer laser.

Medical laser maker Ra Medical Systems (Carlsbad, CA) has received China Food and Drug Administration (CFDA) approval for its Pharos excimer laser to treat psoriasis, vitiligo, and other skin diseases in China.

Related: Ra Medical Systems receives CE Mark approval for atherectomy and laser phototherapy systems

The dermatology laser, which also has CE Mark approval in Europe, will now be available in China as a treatment for China's estimated 26 million psoriasis sufferers. It also gives new hope to China's estimated 13 million vitiligo patients, many of whom have been told there are no treatment options for their disease.

"Medicine is modernizing in China, new hospitals and clinics are opening up, and millions of dermatology patients are gaining access to treatment for their diseases for the first time in their lives," says Jeffrey Kraws, president at Ra Medical Systems.

The company is actively seeking distributors in China.

For more information, please visit www.ramed.com.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)